BeOne Medicines (ONC) Work In Process (2024 - 2026)
BeOne Medicines (ONC) posted quarterly Work In Process of $109.2 million for Q1 2026, down 10.98% quarter-over-quarter from $122.7 million in Q4 2025.
BeOne Medicines (ONC) Work In Process (2024 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Work In Process for 3 consecutive years, with $109.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Work In Process changed N/A year-over-year to $109.2 million; the TTM figure through Mar 2026 stood at $109.2 million (changed N/A YoY), while the FY2025 annual figure was $122.7 million, up 104.07% from the prior year.
- Work In Process fell to $109.2 million in Q1 2026 per ONC's latest filing, from $122.7 million in the prior quarter.
- Across five years, Work In Process topped out at $122.7 million in Q4 2025 and bottomed at $60.1 million in Q4 2024.
- Historically, Work In Process has averaged $97.3 million across 3 years, with a median of $109.2 million in 2026.
- On a YoY basis, Work In Process climbed as much as 104.07% in 2025 and fell as far as 104.07% in 2025.
- BeOne Medicines' Work In Process stood at $60.1 million in 2024, then jumped by 104.07% to $122.7 million in 2025, then retreated by 10.98% to $109.2 million in 2026.
- Business Quant data shows ONC's Work In Process at $109.2 million in Q1 2026, $122.7 million in Q4 2025, and $60.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.32 Mn |
| Mar 31, 2026 | 109.21 Mn |
| Dec 31, 2025 | 122.68 Mn |
| Dec 31, 2024 | 60.12 Mn |